Literature DB >> 11642666

Laparoscopic indirect hernia repair: an evaluation of the ring closure technique.

K R Murshid1.   

Abstract

BACKGROUND: The treatment of indirect inguinal hernias offers a wide variety of surgical methods to choose from. The author has chosen the procedure combining most of the advantages and the fewest disadvantages while at the same time being simple. It entails a simple closure using laparoscopic intraperitoneal intracorporeal suturing of the defect (the internal ring) with nonabsorbable material. PATIENTS AND METHODS: Forty-eight hernias were treated by laparoscopic intracorporeal closure of the internal ring using nonabsorbable suture. No mesh was used. The mean age of the patients was 41.9 years with a mean duration of symptoms of 44.9 months. The mean operating time was 67 minutes per hernia, and the postoperative hospitalization was 1.9 days. The mean follow-up was 32.67 months.
RESULTS: Only one hernia recurred (2%). None of the patients developed serious complications, and only 10 patients complained of port site discomfort.
CONCLUSIONS: Our results indicate that the laparoscopic internal ring closure method is simple, safe, and effective in treating indirect inguinal hernias. In addition, it appears to be cost effective.

Entities:  

Mesh:

Year:  2001        PMID: 11642666     DOI: 10.1089/109264201317054591

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  2 in total

1.  Obstructed bilateral inguinal hernias after robotic-assisted laparoscopic ultra-low anterior resection: an uncommon complication?

Authors:  T H Loong; C Y Ng
Journal:  Tech Coloproctol       Date:  2012-07-20       Impact factor: 3.781

2.  Internal Ring Defect Closure Technique in Laparoscopic Mesh Hernioplasty for Indirect Inguinal Hernia.

Authors:  Binggen Li; Shange Shi; Changfu Qin; Jiwei Yu; Duhui Gong; Xiangyang Nie; Jinchao Miao; Zeru Lai; Wenbo Cui; Guoxin Li
Journal:  Front Surg       Date:  2022-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.